The industry’s competitive landscape features major players such as Chr. Hansen Holding A/S, Kerry Group plc, IFF, ADM, Probi AB, BioGaia AB, and Yakult Honsha Co., Ltd.
The chews are NSF Certified for Sport, ensuring full label accuracy, ingredient purity, and the absence of banned substances.
The company believes SlimFast is well-positioned to benefit from increased consumer demand for protein and nutrition supplementation during and after GLP-1 treatment.
The global probiotics industry, currently valued at US$73 billion, is expected to reach US$110 billion by 2030, driven by consumer demand for gut health.
Fibersol may delay hunger, support the production of appetite-regulating hormones such as GLP-1 and peptide YY.